INS and metabolic dysfunction-associated steatotic liver disease: One pilot randomized study showed that fecal microbiota transplantation from a lean donor to obese NAFLD patients improved hepatic insulin sensitivity and reduced the liver-fat fraction at 6 months—effects that were the greatest when the donor’s stool harbored high microbial diversity [152].